Access Statistics for Diego Useche

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 0 0 0 0 3 33
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 0 0 1 2 3 13
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 1 8
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 0 20
Empirical Economic Analysis of Orphan Drug Innovation 0 0 0 0 0 0 1 11
Empirical Economic Analysis of Orphan Drug Legislation Impact on Innovation 0 0 0 0 0 0 1 33
Empirical economic analysis of orphan drug legislation impact on innovation 0 0 0 0 0 0 0 416
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 3 5 18
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 1 2 13
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 0 0 0 1 2 4 20
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 1 3 6
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 1 1 5
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 0 0 0 1 28
Highly-skilled migrants and Cross-border M&A: Firm-level evidence 0 0 0 48 1 2 5 91
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 16 1 1 2 118
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies. NBER working paper n° w24021 0 0 0 0 0 0 0 8
Orphan Drug Designations as Valuable intangible assets for Ipo Investors in Pharma-biotech companies 0 0 0 0 0 0 0 18
Orphan Drug Designations as valuable Intangible assets for IPO Investors in Pharma-Biotech Companies 0 0 0 0 0 0 2 46
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 0 7 0 0 1 19
Total Working Papers 0 0 0 71 6 13 35 924


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are patents signals for the IPO market? An EU–US comparison for the software industry 0 0 1 44 1 3 10 168
Crowdfunding to overcome the immigrant entrepreneurs’ liability of outsidership: the role of internal social capital 0 0 2 8 2 2 19 53
Highly skilled and well connected: Migrant inventors in cross-border M&As 0 1 2 24 2 4 7 98
Patenting Behaviour and the Survival of Newly Listed European Software Firms 0 0 0 8 0 0 2 37
Where do we go? VC firm heterogeneity and the exit routes of newly listed high-tech firms 0 0 0 8 1 3 6 34
Total Journal Articles 0 1 5 92 6 12 44 390


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Orphan Drug Designations as Valuable Intangible Assets for IPO Investors in Pharma-Biotech Companies 0 0 0 14 0 0 2 85
Total Chapters 0 0 0 14 0 0 2 85


Statistics updated 2025-09-05